Compare LGND to:
After Hours:
1.90
-0.04 (-2.06%) 4:11pm ET
| Last Trade: | 1.94 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 2.02 |
| Open: | 2.01 |
| Bid: | N/A |
| Ask: | 2.39 x 200 |
| 1y Target Est: | 5.00 |
| Day's Range: | 1.94 - 2.04 |
|---|---|
| 52wk Range: | 1.63 - 3.21 |
| Volume: | 319,959 |
| Avg Vol (3m): | 594,008 |
| Market Cap: | 219.25M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.68 |
| Div & Yield: | N/A (N/A) |
| Wed, Nov 25 | 4-Star Stocks on the Upswingat Motley Fool |
| Tue, Nov 24 | LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Other EventsEDGAR Online |
| Mon, Nov 23 | 5 Top Stocks at Half Priceat Motley Fool |
| Mon, Nov 23 | LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online |
| Fri, Nov 20 | Ligand Presents New Preclinical Data on its Lead SARM Molecule LGD-4033 at the Gerontological Society of America Annual MeetingBusiness Wire |
| Thu, Nov 19 | LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online |
| Thu, Nov 19 | Ligand receives $2 million from Merck partnershipAP |
| Thu, Nov 19 | Ligand Earns $2 Million in Milestone Payments from Merck & Co., Inc.Business Wire |
| Fri, Nov 13 | LIGAND PHARMACEUTICALS INC FinancialsEDGAR Online Financials |
| Mon, Nov 9 | LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive AgreementEDGAR Online |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.